Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis With Special Focus on Patient Satisfaction

NCT01368913 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT01368913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis With Special Focus on Patient Satisfaction
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
May 31, 2013
Enrollment
138 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

nocturnal enuresis